Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) Institutional Ownership
CUSIP: 48669G303
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
22
Shares (Excl. Options)
2,479,478
Price
$6.89
- Type / Class
- Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
- Symbol
- KZIA on Nasdaq
- Shares outstanding
- 11,387,333
- Price per share
- $7.44
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 2,479,478
- Total reported value
- $17,070,899
- % of total 13F portfolios
- 0%
- Share change
- +2,151,403
- Value change
- +$14,797,378
- Number of holders
- 22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares is tracked under CUSIP 48669G303.
- 22 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 22 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $17,070,899 to $11,666.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 48669G303?
CUSIP 48669G303 identifies KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 48669G303:
Significant Owners of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 5.4% | $2,107,941,734 | 307,998,500 | Lynwood Capital Management Inc. | 15 Jan 2026 | |||
| Ikarian Capital, LLC | 5.1% | $3,740,056 | 580,754 | Ikarian Capital, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 22 institutional investors reported holding 2,479,478 shares of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA). This represents 22% of the company’s total 11,387,333 outstanding shares.
Top 23 Institutional Shareholders
The largest institutional shareholders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 6.5% | 738,321 | 0.01% | $5,087,032 | |
| Stonepine Capital Management, LLC | 4% | 460,359 | 2.5% | $3,171,874 | |
| Bleichroeder LP | 3.5% | 400,000 | 0.48% | $2,756,000 | |
| Velan Capital Investment Management LP | 2.6% | 300,000 | 1.2% | $2,067,000 | |
| Point72 Asset Management, L.P. | 1.8% | 200,000 | 0% | $1,378,000 | |
| Empery Asset Management, LP | 1.5% | 170,000 | 0% | 1% | $1,171,300 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.61% | 70,000 | 0.08% | $470,246 | |
| ROYAL BANK OF CANADA | 0.48% | 54,133 | 0% | $373,000 | |
| Westside Investment Management, Inc. | 0.27% | 30,875 | 0.03% | $212,734 | |
| BARCLAYS PLC | 0.21% | 23,999 | -0% | 0% | $165,353 |
| Rockefeller Capital Management L.P. | 0.09% | 10,700 | 0% | 0% | $73,723 |
| Engineers Gate Manager LP | 0.09% | 10,388 | 0% | $71,573 | |
| FNY Investment Advisers, LLC | 0.07% | 7,500 | 0.01% | $51,000 | |
| RHUMBLINE ADVISERS | 0.01% | 1,565 | +165% | 0% | $10,779 |
| MORGAN STANLEY | 0.01% | 1,000 | +400% | 0% | $6,890 |
| GAMMA Investing LLC | 0% | 232 | 0% | $1,598 | |
| Arax Advisory Partners | 0% | 200 | 0% | 0% | $1,378 |
| UBS Group AG | 0% | 193 | -95% | 0% | $1,330 |
| OSAIC HOLDINGS, INC. | 0% | 10 | 0% | 0% | $68 |
| Dauntless Investment Group, LLC | 0% | 1 | -100% | 0% | $7 |
| CITIGROUP INC | 0% | 1 | -100% | 0% | $7 |
| Allworth Financial LP | 0% | 1 | 0% | 0% | $7 |
| MAI Capital Management | 0% | 0 | -100% | $0 |